Wearable Cardioverter–Defibrillator after Myocardial Infarction
Wearable Cardioverter–Defibrillator after Myocardial Infarction
About this item
Full title
Author / Creator
Olgin, Jeffrey E , Pletcher, Mark J , Vittinghoff, Eric , Wranicz, Jerzy , Malik, Rajesh , Morin, Daniel P , Zweibel, Steven , Buxton, Alfred E , Elayi, Claude S , Chung, Eugene H , Rashba, Eric , Borggrefe, Martin , Hue, Trisha F , Maguire, Carol , Lin, Feng , Simon, Joel A , Hulley, Stephen , Lee, Byron K and VEST Investigators
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
Patients with acute MI and an ejection fraction of 35% or less were randomly assigned to receive a wearable cardioverter–defibrillator plus medical therapy or medical therapy alone. At 90 days, there was no significant between-group difference in the rate of arrhythmic death.
Alternative Titles
Full title
Wearable Cardioverter–Defibrillator after Myocardial Infarction
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2116121647
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2116121647
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1800781
